Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Buy
80
ACCYY Quote, Financials, Valuation and Earnings
Last price:
$9.88
Seasonality move
:
-1%
Day range:
$9.77 - $9.88
52-week range:
$7.02 - $9.93
Dividend yield:
2.6%
P/E ratio:
19.64x
P/S ratio:
2.34x
P/B ratio:
2.48x
Volume:
68.5K
Avg. volume:
65.5K
1-year change:
28.52%
Market cap:
$11.9B
Revenue:
$5.5B
EPS (TTM):
$0.50
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Accor SA has -- downside to fair value with a price target of -- per share.
ACCYY vs. S&P 500
-
Over the past 5 trading days, Accor SA has overperformed the S&P 500 by 0.08% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Accor SA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Accor SA has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Accor SA reported revenues of --.
Earnings Growth
-
Accor SA has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Accor SA reported earnings per share of --.
Enterprise value:
14.5B
EV / Invested capital:
--
Price / LTM sales:
2.34x
EV / EBIT:
16.38x
EV / Revenue:
2.53x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
35.70x
Price / Operating cash flow:
33.00x
Enterprise value / EBITDA:
11.93x
Gross Profit (TTM):
$2.9B
Return On Assets:
5.54%
Net Income Margin (TTM):
11.97%
Return On Equity:
12.08%
Return On Invested Capital:
7.84%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-17 | 2024-01-17 | 2024-01-17 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.2B | $3.7B | $3B | $3.5B | $2.9B | |
| Total Assets | $12.2B | $12.3B | $11.5B | $12.5B | $12.3B | |
| Current Liabilities | $3.3B | $3.1B | $2.7B | $2.7B | $3.1B | |
| Total Liabilities | $6.8B | $7.2B | $6.4B | $6.5B | $7.1B | |
| Total Equity | $5.4B | $5.1B | $5.1B | $6B | $5.2B | |
| Total Debt | $3.4B | $3.6B | $3.1B | $3B | $3.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2017-06-30 | 2018-06-30 | 2019-06-30 | 2018-06-30 | 2019-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $905.4M | $903M | $579.2M | $50M | $241.2M | |
| Cash From Investing | -$4.3B | $3.3B | -$1.9B | -$272.5M | -$219.3M | |
| Cash From Financing | $2.1B | -$685.4M | -$1B | -$44.3M | -$40.7M | |
| Free Cash Flow | -$2.5B | -$597.1M | -$1.6B | -$182.3M | $33.8M | |
ACCYY
Sector
Market Cap
$11.9B
$464.6M
Price % of 52-Week High
98.69%
71.71%
Dividend Yield
2.6%
0%
Shareholder Yield
10.9%
3.59%
1-Year Price Total Return
28.53%
-10.38%
Beta (5-Year)
1.208
0.958
Dividend yield:
2.6%
Annualized payout:
$0.22
Payout ratio:
47.65%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$9.69
200-day SMA
Buy
Level
$8.79
Bollinger Bands (100)
Buy
Level
8.67 - 9.57
Chaikin Money Flow
Sell
Level
-1.3M
20-day SMA
Buy
Level
$9.69
Relative Strength Index (RSI14)
Buy
Level
57.72
ADX Line
Buy
Level
18.31
Williams %R
Sell
Level
-17.4672
50-day SMA
Buy
Level
$9.47
MACD (12, 26)
Buy
Level
0.07
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
16.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6058)
Buy
CA Score
(Annual)
Level (-0.299)
Buy
Beneish M-Score
(Annual)
Level (-2.5554)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-0.6305)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Accor operates 821,518 rooms across roughly 50 brands addressing the economy through luxury segments as of Dec. 31, 2023. Ibis (economy scale) is the largest brand (35% of total rooms at the end of 2023), followed by midscale brands Mercure (16%) and Novotel (13%). FRHI offers additional luxury and North American exposure. After the sale of the majority of HotelInvest (owned assets) in 2018-19, the majority of total EBITDA comes from asset-light managed and franchised hotels. Europe and North Africa represent 44% of rooms, Asia-Pacific 34%, the Americas 13%, and India, Middle East, and Africa 10%. Premium, midscale, and economy are 86% of total rooms, while luxury and lifestyle are the remaining 14%.
Stock Forecast FAQ
In the current month, ACCYY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ACCYY average analyst price target in the past 3 months is --.
-
Where Will Accor SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Accor SA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Accor SA?
Analysts are divided on their view about Accor SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Accor SA is a Sell and believe this share price will rise from its current level to --.
-
What Is Accor SA's Price Target?
The price target for Accor SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ACCYY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Accor SA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ACCYY?
You can purchase shares of Accor SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Accor SA shares.
-
What Is The Accor SA Share Price Today?
Accor SA was last trading at $9.88 per share. This represents the most recent stock quote for Accor SA. Yesterday, Accor SA closed at $9.80 per share.
-
How To Buy Accor SA Stock Online?
In order to purchase Accor SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will T-Mobile Stock Recover?
Last year was a stellar year for telecom giant T-Mobile…
Why Is Stanley Druckenmiller Buying Citigroup?
As recently as 2020, few analysts could have predicted that…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 112x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
40
NUKK alert for Jan 17
Nukkleus [NUKK] is up 45.98% over the past day.
Sell
45
NUTX alert for Jan 17
Nutex Health [NUTX] is up 2.83% over the past day.
Buy
53
QMCO alert for Jan 17
Quantum [QMCO] is down 15.61% over the past day.
